Table 1—

Summary of surveillance and resistance data

Country^#	Year notification data	Overall incidence notified cases^¶ per 100,000 population	^¶,+Incidence of notified definite cases Pulm C⁺ per 100,000 population	Foreign born %^¶	Year resistance data^¶,§	Any H %	Any MDR %
Czech Republic	1998	17.6	9.2	6	1999	3.2^f,##	1.6^f,##
Denmark	1998	10.0	8.4	65	1998	6.1^##	0.5^##
England & Wales	1998	10.5	6.3	48	1997	5.0^##	0.8^##
Northern Ireland	1998				1997	2.4^##	0.0^##
Scotland	1998				1997	3.7^##	0.3^##
Estonia	1998	57.2	37.5	14	1998	26.0^##	14.1^##
Finland	1998	12.2	6.6	8	1997	4.6^##	0.0^##
France	1998	11.0	2.8	24⁺⁺	1997	3.6^f,¶¶,##	0.0^f,¶¶,##
Germany	1998	12.7	7.3	32⁺⁺	1998	6.2^f,¶¶,##	1.3^f,¶¶,##
Italy	1998	8.4	3.9	17⁺⁺	1998/1999	5.6^f	1.2^f
Latvia	1998	90.0	51.8	3	1998	28.1^##	9.0^##
Netherlands	1998	8.6	4.4	60⁺⁺	1996	6.3^##	0.6^##
Norway	1998	5.5	4	53	1996	8.0^##	2.2^##
Poland	1998	34.4	19.4		1997	2.7^f,##	0.6^f,##
Russian Federation (Tomsk Oblast)	1998	82.7			1999	19.4^f,##	6.5^f,##
Russian Federation (Ivanovo Oblast)	1998	82.7			1998	22.1^##	9.0^##
Slovakia	1998	23.8	13.7	0	1998	2.0^f,##	0.3^f,##
Slovenia	1998	22.5	17.4	0	1997	1.0^##	0.7^##
Spain	1998	22.9	6.5	1	1998	2.2^f,¶¶,§§	0.3^f,¶¶,§§
Sweden	1998	5.0	4.1	60	1997	5.6^##	0.6^##
Switzerland	1998	10.3	8.3	55	1997	2.8^##	0.0^##

Pulm C⁺: pulmonary culture positive C⁺
H: isoniazid
MDR: multidrug-resistance
^#: only countries providing resistance data stratified for previous treatment status were included
^¶: derived from 16
⁺: derived from 18
^§: derived from 17
^f: completed survey
^##: all cases or random selection
^¶¶: sentinel sites
⁺⁺: foreign citizen
^§§: Barcelona city only